Search results for "Opioid responsivene"

showing 2 items of 2 documents

Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients.

2009

Neuropathic pain (NP) is a difficult issue, particularly in cancer which is a dynamic condition where multiple pain etiologies are concomitantly present. Cancer pain is often labeled as mixed mechanism pain and is not easily classified as exclusively nociceptive or NP. The aim of this study was to explore the value of evaluation tools such as Neuropathic Pain Questionnaire (NPQ), complete and short form (NPQ-SF), Leeds Assessment of Neuropathic Signs and Symptoms (LANSS) and Neuropathic Pain Symptom Inventory (NPSI). The secondary outcome was to evaluate the response to opioid titration, according to the hierarchical classification of definite, possible and unlikely NP. A consecutive sample…

Malemedicine.medical_specialtyPainOpioidSensitivity and SpecificityRoute of administrationassessment toolsInternal medicineNeoplasmsmedicineassessment tools; Cancer pain; neuropathic pain; opioid response; Aged; Analgesics Opioid; Female; Humans; Male; Neoplasms; Pain; Pain Measurement; Sensitivity and Specificity; Treatment Outcome; Anesthesiology and Pain Medicine; Neurology; Neurology (clinical)HumansCancer painAgedPain Measurementtools for cancer painneuropathic painopioid responsivenessAnalgesicsbusiness.industryCancerPain scaleneuropathic cancer painmedicine.diseaseAnalgesics OpioidAnesthesiology and Pain MedicineNociceptionTreatment OutcomeNeurologyOpioidopioid responseAnesthesiaNeuropathic painEtiologyFemaleNeurology (clinical)businessCancer painmedicine.drugThe journal of pain
researchProduct

Opioid Responsiveness-Primary Diagnosis Relationship in Advanced Cancer Patients Followed At Home

2000

The aim of this study was to evaluate the influence of the primary cancer on pain characteristics and opioid response, in terms of analgesia and adverse effects, in advanced cancer patients followed at home. A prospective study was carried out in a sample of 434 consecutive advanced cancer patients who required opioids during the last four weeks of life. One hundred eighty-one patients received opioids for longer than the four weeks and were considered for this analysis. Demographic data, primary diagnosis, and pain mechanisms were recorded, and mean opioid doses, pain intensity, and symptoms were assessed at weekly intervals during the last four weeks of life. In the group of 181 patients,…

medicine.medical_specialtyPainHome careProstate cancerUterine cancerNeoplasmsInternal medicinemedicineHumansProspective StudiesMesotheliomaPrimary diagnosis relationshipAdverse effectProspective cohort studyNursing (all)2901 Nursing (miscellaneous)General NursingPain MeasurementOpioid responsivenebusiness.industryCancerVisceral painmedicine.diseaseAnalgesics OpioidAnesthesiology and Pain MedicineOpioidProspective epidemiologic studyAnesthesiaNeurology (clinical)medicine.symptombusinessmedicine.drugJournal of Pain and Symptom Management
researchProduct